Sequence variations of GRM6 in patients with high myopia.

Xiaoyu Xu, Shiqiang Li, Xueshan Xiao, Panfeng Wang, Xiangming Guo, Qingjiong ZhangPubMed 2009

TL;DR

This study investigated the role of the GRM6 gene in high myopia, a common vision disorder. Researchers identified three novel genetic variations in GRM6 in patients with high myopia that are predicted to affect protein function, suggesting a potential, albeit rare, genetic contribution to the development of this condition.

What Problem Does This Paper Address?

High myopia, characterized by severe nearsightedness, is a significant vision problem with a complex etiology. While genetic factors are known to play a role, the specific genes responsible for nonsyndromic high myopia are largely unknown. Congenital Stationary Night Blindness (CSNB) is a related condition where mutations in genes like NYX and GRM6 are implicated. Interestingly, high myopia is frequently observed in patients with CSNB, even when night blindness is not the primary symptom. This observation led the researchers to hypothesize that GRM6, a gene known to be involved in retinal signaling and CSNB, might also contribute to isolated high myopia in some individuals, particularly through rare genetic variations. The problem is to identify specific genetic variations in GRM6 that are associated with high myopia, distinct from its known role in CSNB.

Methods

The researchers employed a candidate gene approach, focusing on the GRM6 gene. They collected DNA from 96 unrelated Chinese patients diagnosed with high myopia (spherical equivalent of -6.00D or worse) and 96 unrelated healthy controls with normal vision. The entire coding region and adjacent intronic sequences of the GRM6 gene were amplified using polymerase chain reaction (PCR). These amplified fragments were then analyzed using cycle sequencing to detect any variations.

To confirm the significance of detected variations, particularly those predicted to have functional consequences, the researchers used two methods: heteroduplex-single-strand-conformation polymorphism (HA-SSCP) analysis and polymerase chain reaction combined with restriction fragment length polymorphism (PCR-RFLP) analysis. These techniques allowed them to efficiently screen the control group for the presence of the identified variations.

Bioinformatic tools were utilized to predict the potential functional impact of the identified variations. These included PolyPhen and SIFT for assessing the pathogenicity of amino acid substitutions, and ASSA and BDGP for predicting alterations in splicing sites.

Datasets

The study utilized two primary datasets:

  • High Myopia Patient Cohort: 96 unrelated Chinese patients with high myopia.
  • Normal Control Cohort: 96 unrelated Chinese individuals with normal vision and no family history of high myopia.

No new benchmarks or datasets were introduced in this study.

Key Insights and Ideas

  • Beyond CSNB: GRM6 in Isolated High Myopia: The study moves beyond the established link between GRM6 and CSNB to explore its potential role in high myopia that occurs independently of night blindness. This broadens the scope of genes to consider for complex vision disorders.
  • Rare Variants Matter: The findings highlight the importance of searching for rare genetic variations (common disease, rare variant - CDRV) in complex diseases like high myopia, as common variants (common disease, common variant - CDCV) may not fully explain the genetic architecture.
  • Functional Predictions are Crucial: The use of bioinformatic tools to predict the functional impact of genetic variations is key. Identifying variations that alter protein structure or function provides stronger evidence for their involvement in disease.
  • Ethnic Specificity Considerations: While this study focused on a Chinese population, the authors suggest that further studies in other ethnic groups are needed to confirm their findings, acknowledging potential ethnic variations in gene associations.

Key Results

The study identified a total of four novel variations predicted to have potential functional consequences in the GRM6 gene among the 96 high myopia patients:

  • c.67-82delCAGGCGGGCCTGGCGCinsT (p.Gln23_Arg28delinsCys): This variation, a deletion and insertion within exon 1, was found in one patient and not in controls. It results in the deletion of six amino acids and the addition of cysteine. Analysis suggested this region might not be highly conserved.
  • c.858-5a>g (r.spl?): This intronic variation was found in one patient and not in controls. It was predicted to cause a weak effect on splicing.
  • c.1172G>A (p.Arg391Gln): This variation was found in four controls and two patients, with no statistically significant difference between the groups. It leads to an amino acid substitution, but was predicted to be "benign" or "tolerated" by bioinformatic tools.
  • c.1537G>A (p.Val513Met): This variation was found in three high myopia patients (two heterozygous, one homozygous) and not in controls. It results in a substitution of valine with methionine and is predicted to form a conserved extracellular domain.

Crucially, three of these four novel variations (c.67-82delCAGGCGGGCCTGGCGCinsT, c.858-5a>g, and c.1537G>A) were not detected in the control group, suggesting they are specific to the high myopia patients. The variation c.1172G>A was found in both groups, diminishing its significance as a sole cause of high myopia.

In addition to these novel variations, five rare variations and one common variation without predicted functional consequences, along with nine known single nucleotide polymorphisms (SNPs), were also detected in the patients.

Limitations and Future Work

Limitations: * Small Sample Size: The study involved 96 patients and 96 controls, which is a relatively small sample size for detecting rare variants and establishing definitive associations for complex diseases. * Case-Control Study: While informative, a case-control study design cannot definitively prove causality. The presence of a variant in patients does not automatically mean it causes the disease. * Functional Validation: The study relied on in silico predictions for the functional impact of the variations. Direct experimental validation of these predicted effects (e.g., through cell-based assays or animal models) was not performed. * Ethnic Specificity: The findings are based on a Chinese population, and their generalizability to other ethnic groups remains to be determined.

Future Work: * Replication in Larger Cohorts: The authors emphasize the need for further studies in larger cohorts, particularly from different ethnic backgrounds, to validate these findings and increase statistical power. * Functional Studies: Experimental validation of the identified novel variations is crucial to confirm their impact on GRM6 protein function and downstream signaling pathways. * Broader Gene Screening: Investigating other candidate genes involved in retinal function and myopia development would be beneficial. * Investigating Interactions: Exploring potential interactions between GRM6 variations and other genetic or environmental factors could provide a more comprehensive understanding of myopia etiology.

Summary updated

Abstract

Three novel variations with potential functional consequences were identified in the GRM6 of patients with high myopia, suggesting a potential role in the development of myopia in rare cases.
BibTeX
@inproceedings{xu2009sequence,
  author = {Xiaoyu Xu and Shiqiang Li and Xueshan Xiao and Panfeng Wang and Xiangming Guo and Qingjiong Zhang},
  title = {{Sequence variations of GRM6 in patients with high myopia.}},
  booktitle = {PubMed},
  year = {2009},
}
Figure